Skip to main content

Table 2 Pain free rate at 2 hours and headache recurrence rate at 24 hours and 48 hours for all migraine with aura attacks

From: Efficacy of frovatriptan as compared to other triptans in migraine with aura

 

Rizatriptan

zolmitriptan

Almotriptan

Frovatriptan

Significance

 

(n = 28)

(n = 24)

(n = 8)

(n = 57)

 

Baseline headache intensity1

 

mean

2.4 +/− 0.5

2.2 +/− 0.6

2.3 +/− 0.7

2.1 +/− 0.7

ns

 

median

2

2

2

2

ns

Pain free at

      
 

2 hours

10.7%

25.0%

12.5%

29.8%

p < 0.052

 

4 hours

35.7%

50.0%

25.0%

50.9%

ns

Recurrence at

      
 

24 hours

42.9%

37.5%

37.5%

26.3%

p < 0.053

 

48 hours

89.3%

91.7%

87.5%

66.7%

p < 0.014

  1. 1Headache intensity graded as 0 = none; 1 = mild; 2 = moderate; 3 = severe.
  2. 2p < 0.05 for comparison between frovatriptan and rizatriptan.
  3. 3only for comparison between frovatriptan and rizatriptan.
  4. 4post-hoc analysis: p = 0.025 for frovatriptan versus rizatriptan; p = 0.019 for frovatriptan versus zolmitriptan; p = 0.232 for frovatriptan versus almotriptan.
  5. Data are shown as mean (+/− SD), or frequency in %. Statistical comparison by ANOVA or Chi2-test (ns denotes not significant).